Effect of Carvedilol Versus Carvedilol/Ivabradine Combination on Heart Rate, Quality of Life, Morbidity and Mortality in Patients with Stable Ischemic Heart Failure

Trial Profile

Effect of Carvedilol Versus Carvedilol/Ivabradine Combination on Heart Rate, Quality of Life, Morbidity and Mortality in Patients with Stable Ischemic Heart Failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2013

At a glance

  • Drugs Ivabradine (Primary) ; Carvedilol
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2013 New trial record
    • 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top